Reactions Weekly

, Volume 1694, Issue 1, pp 375–375 | Cite as


Rash: case report
Case report


  1. Moser S, et al. Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. European Journal of Gastroenterology and Hepatology 30: 291-295, No. 3, Mar 2018. Available from: URL: -AustriaPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations